The impact of the HPV vaccine in preventing cervical cancer in women is well demonstrated, and little by little the world is also beginning to incorporate the vaccine in men, not only to further reduce the rate of genital tumors but also also those of mouth, throat etc. But this recent study has also seen that there is a link between men with serological evidence (antibodies) of exposure to multiple strains of the papillomavirus being a risk factor for prostate cancer. It is yet another reason to consider vaccinating all men.

You can read the full study by clicking the button below.

Lawson, JS, Glenn, WK Evidence for a causal role by human papillomaviruses in prostate cancer – a systematic review. Infect Agents Cancer  15  41 (2020).

Learn more.